Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News
Financial Results · Q3 2026

TherapeuticsMD Q3 2026 Results: Net Income $491K, Up 223.0% YoY

TherapeuticsMD reported net income of $0.49 million for the quarter ended September 30, 2026, compared to $0.15 million in the prior year period, driven by increased license revenue from its royalty-based business model. The company maintained a stable balance sheet with $10.4 million in cash and total stockholders' equity of $27.6 million.

Q3 2026 at a glance · $ million
MetricQ3 2026Q3 2025
Revenue1.30.8
Profit before tax0.50.1
Net income0.50.2
EPS (diluted, $ a share)$0.04$0.01

A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.

Growth and margins
Net income, year on year+223.0%
Revenue, year on year+60.6%
Operating margin-38.0%
Source

10-Q filed with the SEC, NASDAQ: TXMD. Figures from the filing's XBRL data; summary written with AI assistance from the filing.

Read the filing ↗

TherapeuticsMD, Inc.: key numbers

Share price
$1.81Close, Nov 16
Market cap
$20.9M
Shares outstanding
11.57MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers, updated daily. Not a valuation or a recommendation.

More from TherapeuticsMD, Inc.

All →
4:07 PM ET 8-K
Financial Results

TherapeuticsMD Financial Results

TherapeuticsMD reported third quarter 2026 financial results, highlighting license revenue of $1.3 million, a 60.6% increase year-over-year. The company achieved a $0.5 million net income from continuing operations and ended the period with $10.4 million in cash. Management noted the achievement of a sales-based milestone for IMVEXXY and continues to evaluate strategic alternatives including potential mergers or asset sales.

Term
Q3 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.